Document is current
Any future updates will be listed below
-
Authors
Hammoud, Rola
Drucker, Daniel J. http://orcid.org/0000-0001-6688-8127
- License Information
-
More Information
Article History
Accepted: 17 November 2022
First Online: 12 December 2022
Competing interests
: D.J.D. has received speaking or consulting funds from Altimmune, Amgen, Eli Lilly, Kallyope, Merck, Novo Nordisk Inc. and Pfizer Inc. Preclinical studies in the Drucker laboratory are funded in part by investigator-initiated operating grants to Sinai Health from Novo Nordisk Inc. and Pfizer Inc. R.H. declares no competing interests.
